We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
-5.94%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$5.24B
AUM Growth
-$312M
Cap. Flow
+$100M
Cap. Flow %
1.91%
Top 10 Hldgs %
19.63%
Holding
588
New
50
Increased
219
Reduced
167
Closed
31

Top Sells

Rank Stock Value
1
FL
Foot Locker
FL
+$42.5M
2
WMT icon
Walmart Inc
WMT
+$15.2M
3
JPM icon
JPMorgan Chase
JPM
+$14.9M
4
ENOV icon
Enovis
ENOV
+$14.8M
5
PH icon
Parker-Hannifin
PH
+$12.7M

Sector Composition

Rank Sector Weight
1 Technology 31.7%
2 Healthcare 18.75%
3 Consumer Discretionary 11.87%
4 Financials 9.73%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WRB icon
476
W.R. Berkley
WRB
$26.6B
$302K 0.01%
6,750
MKL icon
477
Markel Group
MKL
$23.2B
$299K 0.01%
200
OWL icon
478
Blue Owl Capital
OWL
$18.5B
$297K 0.01%
23,460
AFG icon
479
American Financial Group
AFG
$12.1B
$295K 0.01%
2,000
ALLO icon
480
Allogene Therapeutics
ALLO
$694M
$294K 0.01%
31,400
-9,400
-23% -$97.9K
EDIT icon
481
Editas Medicine
EDIT
$442M
$293K 0.01%
+15,000
New +$279K
LYEL icon
482
Lyell Immunopharma
LYEL
$360M
$289K 0.01%
+2,700
New +$327K
FICO icon
483
Fair Isaac
FICO
$22.5B
$288K 0.01%
600
CDW icon
484
CDW
CDW
$17B
$282K 0.01%
1,575
-9,481
-86% -$1.73M
ALEC icon
485
Alector
ALEC
$199M
$276K 0.01%
+19,000
New +$301K
VERV
486
DELISTED
Verve Therapeutics
VERV
$274K 0.01%
+11,300
New +$323K
SEE
487
DELISTED
Sealed Air
SEE
$273K 0.01%
4,000
-1,500
-27% -$99.9K
RCKT icon
488
Rocket Pharmaceuticals
RCKT
$394M
$266K 0.01%
16,700
PSTH
489
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$264K 0.01%
13,250
NKTR icon
490
Nektar Therapeutics
NKTR
$2.58B
$261K 0.01%
3,120
CCCC icon
491
C4 Therapeutics
CCCC
$412M
$258K ﹤0.01%
+10,700
New +$260K
RXRX icon
492
Recursion Pharmaceuticals
RXRX
$1.73B
$239K ﹤0.01%
+33,500
New +$356K
PVH icon
493
PVH
PVH
$4.04B
$232K ﹤0.01%
2,800
-200
-7% -$18.5K
SGMO
494
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$225K ﹤0.01%
38,000
ERAS icon
495
Erasca
ERAS
$6.39B
$225K ﹤0.01%
+25,000
New +$290K
IMGN
496
DELISTED
Immunogen Inc
IMGN
$223K ﹤0.01%
+47,000
New +$260K
AVXL icon
497
Anavex Life Sciences
AVXL
$310M
$221K ﹤0.01%
+18,000
New +$221K
WFG icon
498
West Fraser Timber
WFG
$5.65B
$216K ﹤0.01%
2,500
-850
-25% -$79.9K
GWW icon
499
W.W. Grainger
GWW
$60.2B
$209K ﹤0.01%
+405
New +$199K
ARQT icon
500
Arcutis Biotherapeutics
ARQT
$3.18B
$208K ﹤0.01%
11,100

Similar funds

Erste Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, Erste Asset Management held 588 positions worth $5.24B, down 5.6% from $5.55B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Erste Asset Management's Q1 2022 filing shows 50 new, 219 increased, 167 reduced and 31 closed positions. Its largest new stake was Houghton Mifflin Harcourt Company: 920,000 shares worth $19.3M. The largest sale was Foot Locker, an estimated $42.5M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Erste Asset Management's largest Q1 2022 buy was Houghton Mifflin Harcourt Company: 920,000 shares worth $19.3M.
  • Erste Asset Management added most to Pfizer in Q1 2022, an estimated $26.5M increase.
  • Erste Asset Management's biggest Q1 2022 reduction was Walmart Inc, cutting an estimated $15.2M.
  • Erste Asset Management fully exited Foot Locker in Q1 2022, selling an estimated $42.5M.
  • Erste Asset Management's ten largest holdings make up 20% of its $5.24B portfolio in Q1 2022.
  • Erste Asset Management opened 50 new positions and closed 31 in Q1 2022.
  • Erste Asset Management's portfolio value fell 5.6% quarter-over-quarter to $5.24B.

Based on Erste Asset Management's 13F filing for Q1 2022, filed 25 Nov 2024.